Glaxo Investors Vie For Lead Plaintiff Role
Three parties vying to serve as lead plaintiff in a securities action against pharmaceutical giant GlaxoSmithKline PLC exchanged volleys Friday, each arguing it is best-suited to represent the proposed class of...To view the full article, register now.
Already a subscriber? Click here to view full article